Oncology (2) Flashcards

1
Q

Aims of treatment

Curative, adjuvant and palliative

A
  • Curative
    • Aims for the complete cure of the disease
    • Rarely possible for solid tumours with chemotherapy alone (surgery is often used)
    • Haematological cancers; a cure is possible with chemotherapy alone, though radiotherapy may be used as well
  • Adjuvant
    • Treatment is given to prevent the return of cancer, following local treatment
    • NB- Neoadjuvant treatment is when a tumour is too large to be easily removed
  • Palliative
    • Aims to control cancer, and attempts to prolong life and reduce symptoms
    • NB- Palliative treatment should not be confused with palliative care
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Types of treatment

A
  • Surgical
  • Radiotherapy
  • Chemotherapy
    • Cytotoxic agents
    • Hormonal therapies
    • Immunomodulation
    • Targeted treatments
    • Biological therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The terminology of describing chemotherapy

A
  • Induction- high dose combination chemotherapy, given with the intent of inducing a complete remission when initiating curative chemotherapy
  • Consolidation- repetition of the induction regimen, with the intention of increasing cure rate or prolonging remission
  • Intensification- chemotherapy after complete remission, often with higher doses and/or alternate combinations, with the intention of increasing cure or remission duration
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Terminology for describing chemotherapy (2)

A
  • Maintenance- long term usually low dose or biological therapy in patients who have achieved complete remission, with the intention of delaying re-growth of micro-residual disease
  • Adjuvant- a course of chemotherapy in patients with no evidence of residual cancer after surgery or radiotherapy, given with the intent of destroying any residual tumour cells
  • Neo-adjuvant- a course, usually shorter than adjuvant chemotherapy, given with the intent of down-sizing the primary tumour to make it more amenable to surgery or radiotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Terminology for describing chemotherapy (3)

A
  • Palliative- chemotherapy is given to control symptoms or prolong life in patients in whom cure is unlikely
  • Salvage- potentially curative combination chemotherapy given to patients who have failed or recurred after curative chemotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Principles of chemotherapy

A
  • re watch
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Chemotherapy treatment (SCLC)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of common chemotherapy regimens

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Principles of combination chemotherapy- a selection of drugs for combinations

A
  • Drugs with known single-agent activity- drugs with the potential for complete remission should be included
  • Drugs with different mechanisms of action
  • Groups of drugs which have shown additive or synergistic activity
  • Drugs with different dose-limiting toxicities, so that individual agents can be given at their maximum dose, without overlapping toxicities so minimising the damage to anyone organ
  • Drugs should be used at their optimal dose and schedule
  • Drugs with different patterns or mechanisms of cellular resistance should be combined to minimise cross-resistance
  • The treatment-free interval should be minimised with the cycle length been the shortest recovery time of the most sensitive normal tissue
    *
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First-line chemotherapy for advanced malignant disease: treatment intent

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cancer tends to involve multiple mutations

A
  • Benign tumour cells grow only locally and cannot spread by invasion or metastasis
  • Malignant cells invade neighboring tissues, enter blood vessels, and metastasize to different sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why does chemotherapy fail

A
  • Failure to achieve log kill
  • Existence of multiple resistant or non-responsive clones
  • Tumour sanctuary sites- brain, testes
  • Pharmacological- altered, by mutation or up or down-regulation of required proteins; drug activation/inactivation
  • Increased repair of drug-induced cell damage
  • Altered drug targets
  • Utilisation of alternative intra /intercellular pathways
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How cancer develops resistant to the P-gp pump

A
  • Over expression of MDR1 (multi-drug resistant) gene which encodes for a cell surface P-gp
  • This is an energy dependent flux pumps which naturally removes toxins or endogenous metabolites from the cell
  • Tumours that intrinsically express the MDR1 gene prior to chemotherapy are characteristically resistant to chemotherapy from the outset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

More lines of chemotherapy

A
  • There has been massive increase in utilization fo chemotherapy
    • Around 60% in 4 years
  • Undoubted benefits for many thousands of patients
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do we dose chemotherapy

A
  • On the concept of BSA, a patient individual calculation based on height (Ht) and Weight (Wt)
  • This gives the formula
    • Surface area= weight0.425 x height0.725 x 71.89
  • Commonly and accurately (for adults) simplified to
  • Surface area = SqR Height (Cm) X Weight (Kg) / 3600
  • Overweight patients use IBW or ABW (adjusted body weight)
17
Q

Even before we get there

A
  • Height
  • Weight
    • Actual body weight- ABW
      • What about Ascites
      • What about fat
    • Ideal body weight- BMI
    • Healthy fat v unhealthy fat
18
Q

The imponderable factor

A
  • Of 7,875 scales used by the NHS for weighing patients
  • 22% not set to zero
  • 33% were inaccurate
  • 40% switched confusingly between metric and imperial with 4% set to imperial
  • 16% of trusts didn’t train staff in the use of scales
19
Q

Other patient characteristic influencing drug toxicity

A
  • Extent of previous treatment: both chemotherapy and radiation deplete stem cell populations
  • Performance status: often correlates with high tumour burden
  • Age: a variety of mechanisms, e.g. reduced clearance
  • Reduced drug-protein binding, results in higher unbound fraction, e.g. cachexia
  • Pharmacogenomics: different polymorphisms account for different responses to different drugs. Rare deficiency states result in major toxicity
  • Pre-existing damage to target organs affects the functional impact of side effects
20
Q

How can we schedule chemotherapy

This is dependent on the type of cancer and treatment goals

A
  • Conventionally 3 weekly
  • Dose-dense weekly
  • Dose intense
  • Plain high dose
  • Alternating
  • Sequential
21
Q

Routes of administration

A
22
Q

What we need to think about

Application, Balance, Context

A
  • Application
    • Drugs, schedule, form, route, stability
  • Balance
    • Efficacy, toxicity, safety, cost, deliverability
  • Context
    • Adjuvant, curative, palliative
23
Q

Chemotherapy agents

A
  • Mechanism of action
  • Activity spectrum (what is it used for and what does it achieve)
  • Toxicities
  • Dose-limiting toxicity
  • Elimination
  • Combinability
  • Synergism with other drugs (efficacy and toxicity)